WGs1&2, targeted at stakeholders in the ‘analysis arena’, address objectives R1 and C1, delivering:
- assessment of analytical capacities for pan-European contaminant assessments with raptors
- the framework European Raptor Biomonitoring Scheme (ERBioMS)
- a network of analytical labs, and
- pilot joint assessments and reporting for proof of concept.\
WG2 focuses on PPPs, biocides and NSAIDs and engages in particular stakeholders in EU PPP, Biocides and Medicinal Products law.
'Analysis Arena' tasks are divided between two WGs (WG1, WG2) because they engage different contaminants, different laws/policies, different agencies (WG1 is largely ECHA-related, WG2 largely EFSA-related) and, in some cases, different researchers.
These two WGs however work closely together and take a common approach, adopting read-across (between types of compounds) ideas and methodologies as appropriate. Meetings/ workshops are held in parallel, and there will be a joint Training School, allowing for joint sessions to ensure synergies and consistency between the two WGs. Synergies will be created through agreement between WGs1 & 2, per set of compounds, on which species and matrices should and can be monitored and where read-across for species is appropriate.
For forthcoming and past meetings involving WG2, see Meetings & Events
For calls for missions and current and past missions relating to WG2, see Missions
WG2 Leader: Antonio Garcia-Fernandez, University of Murcia, Spain - Email: email@example.com